Sign In
Buy MMSI
$67.27
+0.770 (+1.16%)
At Close: Jun 23, 2026
Merit Medical (MMSI) Up 18.4% Since Last Earnings Report: Can It Continue?
12:00am, Saturday, 23'rd May 2020Here's Why You Should Retain Merit Medical (MMSI) for Now
08:15am, Wednesday, 20'th May 2020
Investor confidence is high in Merit Medical (MMSI) stock, thanks to solid prospects.
Research Report with COVID-19 Forecasts-Surgical Scalpel Market 2020-2024 | Increase in Volume of Surgeries to Boost Growth | Technavio
12:00am, Wednesday, 20'th May 2020
The surgical scalpel market size has the potential to grow by USD 105.29 million during 2020-2024
NYSE:MMSI Investor Notice: Lawsuit against Merit Medical Systems, Inc. announced by Shareholders Foundation
11:15am, Tuesday, 19'th May 2020
SAN DIEGO, CA / ACCESSWIRE / May 19, 2020 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in (NYSE:MMSI) shares. Investors, who purchased shares of Merit
Activist Starboard Builds New Stakes in ACI Worldwide, Resideo - BNN Bloomberg
09:03pm, Friday, 15'th May 2020
Activist investor Starboard Value built new positions in payments processor ACI Worldwide Inc. and Resideo Technologies Inc. during the first quarter.
Starboard Value Takes Share Stake In Merit Medical Systems Of 4.8M Shares
07:31pm, Friday, 15'th May 2020Gastrointestinal Stents Market Insights, 2020-2025 by Product Type, Technology Type, Material, End-user and Region - ResearchAndMarkets.com
12:00am, Wednesday, 13'th May 2020
The
May 12, 2020 (The Expresswire) --
Final Report will add the analysis of the impact of COVID-19 on this industry The“Intestinal Stents Market”2020 report...
Shareholder Alert: Robbins LLP Announces It Is Investigating Merit Medical Systems, Inc. (MMSI) for Misleading Shareholders
11:13pm, Thursday, 07'th May 2020
Shareholder rights law firm Robbins LLP announces that it is investigating Merit Medical Systems, Inc. (NASDAQ: MMSI) for alleged violations of the Securities Exchange Act of 1934 and whether the Comp
Shareholder Alert: Robbins LLP Announces It Is Investigating Merit Medical Systems, Inc. (MMSI) for Misleading Shareholders
12:00am, Thursday, 07'th May 2020
Shareholder rights law firm Robbins LLP announces that it is investigating Merit Medical Systems, Inc. (NASDAQ: MMSI) for alleged violations of the Se
Stryker (SYK) Gets a Hold Rating from Oppenheimer
01:01pm, Friday, 01'st May 2020
Oppenheimer analyst Steven Lichtman maintained a Hold rating on Stryker (SYK) today and set a price target of $200.00. The company's shares closed last
Stryker (SYK) Gets a Hold Rating from Oppenheimer
01:01pm, Friday, 01'st May 2020
Oppenheimer analyst
Steven Lichtman
maintained a
Hold
rating on Stryker (
SYK
–
Research Report
) today and set a price target of
$200.00
. The company’s shares closed last Thursday at $186.43.
Ac
Analysts' Top Healthcare Picks: Lemaitre Vascular (LMAT), Aerie Pharma (AERI)
12:51pm, Friday, 01'st May 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lemaitre Vascular (LMAT), Aerie Pharma (AERI) and BioLife
Analysts’ Top Healthcare Picks: Lemaitre Vascular (LMAT), Aerie Pharma (AERI)
12:51pm, Friday, 01'st May 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lemaitre Vascular (
LMAT
–
Research Report
), Aerie Pharma (
AERI
–
Research Report
) and BioLife S
Oppenheimer Assigns a Buy Rating on Tandem Diabetes Care (TNDM)
11:59am, Friday, 01'st May 2020
In a report released today, Steven Lichtman from Oppenheimer assigned a Buy rating to Tandem Diabetes Care (TNDM), with a price target of $92.00. The
